Mirabegron and Tecfidera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirabegron (mirabegron) and Tecfidera (dimethyl fumarate). Common drug interactions include gait disturbance among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Mirabegron and Tecfidera. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

On Jul, 12, 2026

47 people who take Mirabegron and Tecfidera together, and have interactions are studied.

Mirabegron and Tecfidera drug interactions.

What are the common drug interactions of Mirabegron and Tecfidera, by gender? *:

female:

Gait disturbance
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Muscular weakness (muscle weakness)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Fall
Hypercholesterolaemia (high levels of cholesterol in the blood)
Implant site extravasation
Intestinal obstruction
Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
Osteoporosis (bones weak and more likely to break)

male:

Depression
Palpitations (feelings or sensations that your heart is pounding or racing)
Gait disturbance
Joint swelling
Mood altered (changes in mood)
Nausea (feeling of having an urge to vomit)
Nocturia (the need to get up in the night to urinate)
Peripheral swelling
Sensory loss (senses loss)
Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the common drug interactions of Mirabegron and Tecfidera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Ovarian cancer stage iii
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Escherichia sepsis (bacterial infection by escherichia coli)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary oedema (fluid accumulation in the lungs)

30-39:

n/a

40-49:

Dental caries
Dysgeusia (disorder of the sense of taste)
Muscular weakness (muscle weakness)
Vomiting

50-59:

Herpes zoster
Oral herpes (viral infection of mouth)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Depression
Drug hypersensitivity
Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
Neuralgia (pain in one or more nerves)
Palpitations (feelings or sensations that your heart is pounding or racing)
Tooth fracture

60+:

Hemiparesis (weakness on one side of the body)
Depression
Dermatitis diaper (diaper rash is a common form of inflamed skin)
Dizziness
Fatigue (feeling of tiredness)
Feeding disorder (when children refuse to eat certain food groups)
Feeling hot
Gastrointestinal infection (infection of stomach and intestine)
Hypersensitivity
Joint stiffness

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 14 people, 29.79%
Gait Disturbance: 9 people, 19.15%
Pain: 6 people, 12.77%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 6.38%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and Tecfidera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously